Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the 23rd Annual Craig-Hallum Institutional Investor Conference taking place in Minneapolis, Minnesota. Mr. O’Connor will host one-on-one meetings with institutional investors on Thursday, May 28, 2026.

For more information about the events or questions about registration, interested parties should reach out to their contacts at Craig-Hallum.

About Simulations Plus, Inc.

Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through innovative science-based software and consulting solutions. For more information, visit www.simulations-plus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260521068107/en/

Financial Profiles
Lisa Fortuna
310-622-8251
[email protected]

Source: Simulations Plus, Inc.

You May Also Be Interested In

• WISeKey and SEALSQ Establish Quantisimo Corp. as a Special Purpose Vehicle, and Execute Letter of Intent with GigCapital8 Corp.
• WISeKey and SEALSQ Establish Quantisimo Corp. as a Special Purpose Vehicle, and Execute Letter of Intent with GigCapital8 Corp.
• H2SITE Secures New Strategic Investment to Accelerate Industrial Deployment of Hydrogen Production and Separation Solutions